Marlene Oscar Berman, PhD

Professor, Anatomy & Neurobiology

Marlene Berman
72 E. Concord St Instructional (L)


My expertise covers the neuropsychological deficits and intact skills of a variety of neurological populations, including alcoholics with and without clinical signs of Korsakoff’s syndrome (severe amnesia for events occurring since the onset of extensive brain damage). I am familiar with many experimental paradigms that are employed to detect subtle differences in the behavior of alcoholics compared to that of healthy nonalcoholic controls and neurological patients who have incurred brain damage from other than alcohol-related etiologies. I can evaluate behavioral data as well as conceptual findings from structural and functional brain imaging studies.

Other Positions

  • Graduate Faculty (Primary Mentor of Grad Students), Boston University School of Medicine, Division of Graduate Medical Sciences
  • Professor, Neurology, Boston University School of Medicine
  • Professor, Psychiatry, Boston University School of Medicine


  • University of Connecticut, PhD
  • Bryn Mawr College, MA
  • University of Pennsylvania, BA


  • Published on 4/26/2016

    Vitali M, Napolitano C, Berman MO, Minuto SF, Battagliese G, Attilia ML, Braverman ER, Romeo M, Blum K, Ceccanti M. Neurophysiological Measures and Alcohol Use Disorder (AUD): Hypothesizing Links between Clinical Severity Index and Molecular Neurobiological Patterns. J Addict Res Ther. 2016 04; 5(2). PMID: 28090374.

    Read at: PubMed
  • Published on 1/1/2016

    Oscar-Berman M, Urban TA, Holmes AJ. Oxford Handbook of Substance Use Disorders. K. Sher (Ed.). Effects of alcoholism on neurological function and disease in adulthood. Oxford. New York. 2016; 2:355-272.

  • Published on 6/1/2015

    McLaughlin T, Blum K, Oscar-Berman M, Febo M, Agan G, Fratantonio JL, Simpatico T, Gold MS. Putative dopamine agonist (KB220Z) attenuates lucid nightmares in PTSD patients: role of enhanced brain reward functional connectivity and homeostasis redeeming joy. J Behav Addict. 2015 Jun; 4(2):106-15. PMID: 26132915.

    Read at: PubMed
  • Published on 5/14/2015

    Blum K, Thanos PK, Badgaiyan RD, Febo M, Oscar-Berman M, Fratantonio J, Demotrovics Z, Gold MS. Neurogenetics and gene therapy for reward deficiency syndrome: are we going to the Promised Land? Expert Opin Biol Ther. 2015 Jul; 15(7):973-85. PMID: 25974314.

    Read at: PubMed
  • Published on 5/5/2015

    Sawyer KS, Poey A, Ruiz SM, Marinkovic K, Oscar-Berman M. Measures of skin conductance and heart rate in alcoholic men and women during memory performance. PeerJ. 2015; 3:e941. PMID: 26020002.

    Read at: PubMed
  • Published on 2/6/2015

    Modestino EJ, Blum K, Oscar-Berman M, Gold MS, Duane DD, Sultan SGS, Auerbach SH. Reward Deficiency Syndrome: Attentional/Arousal Subtypes, Limitations of Current Diagnostic Nosology, and Future Research. J Reward Defic Syndr. 2015; 1(1):6-9. PMID: 26306327.

    Read at: PubMed
  • Published on 2/1/2015

    Knapp CM, Ciraulo DA, Sarid-Segal O, Richardson MA, Devine E, Streeter CC, Oscar-Berman M, Surprise C, Colaneri L, Putnam M, Waters M, Richambault C. Zonisamide, topiramate, and levetiracetam: efficacy and neuropsychological effects in alcohol use disorders. J Clin Psychopharmacol. 2015 Feb; 35(1):34-42. PMID: 25427171.

    Read at: PubMed
  • Published on 1/1/2015

    Blum K, Thanos PK, Oscar-Berman M, Febo F, Baron D, Badagaiyan RD, Gardner E, Demetrovicks Z, Fahike C, Haberstick BC, Dushaj K, Gold MS . Dopamine in the brain: Hypothesizing surfeit or deficit links to reward and addiction. Journal of Reward Deficiency Syndrome. 2015; 1(3):87-96.

    Read at: Custom
  • Published on 1/1/2015

    Ruiz SM, Oscar-Berman M. The SAGE Encyclopedia of Alcohol: Social, Cultural, and Historical Perspectives. Volume 2. Gender and alcohol abuse: History and sociology. SAGE Publications. Los Angeles. 2015; 2:586-591.

  • Published on 1/1/2015

    Blum K, Oscar-Berman M, Braverman ER, Febo M, Li M, Gold MS. Enhancing Brain Pregnenolone May Protect Cannabis Intoxication but Should Not Be Considered as an Anti-addiction Therapeutic: Hypothesizing Dopaminergic Blockade and Promoting Anti-Reward. J Reward Defic Syndr. 2015; 1(1):20-23. PMID: 26306328.

    Read at: PubMed

View 206 more publications: View full profile at BUMC

View all profiles